Global Hirudin Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Hirudin market size is predicted to grow from US$ 4131 million in 2025 to US$ 4996 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.
LP Information, Inc. (LPI) ' newest research report, the “Hirudin Industry Forecast” looks at past sales and reviews total world Hirudin sales in 2024, providing a comprehensive analysis by region and market sector of projected Hirudin sales for 2025 through 2031. With Hirudin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hirudin industry.
This Insight Report provides a comprehensive analysis of the global Hirudin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hirudin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hirudin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hirudin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hirudin.
This report presents a comprehensive overview, market shares, and growth opportunities of Hirudin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Hirudin market?
What factors are driving Hirudin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hirudin market opportunities vary by end market size?
How does Hirudin break out by Type, by Application?
The global Hirudin market size is predicted to grow from US$ 4131 million in 2025 to US$ 4996 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.
LP Information, Inc. (LPI) ' newest research report, the “Hirudin Industry Forecast” looks at past sales and reviews total world Hirudin sales in 2024, providing a comprehensive analysis by region and market sector of projected Hirudin sales for 2025 through 2031. With Hirudin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hirudin industry.
This Insight Report provides a comprehensive analysis of the global Hirudin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hirudin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hirudin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hirudin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hirudin.
This report presents a comprehensive overview, market shares, and growth opportunities of Hirudin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Natural Hirudin
- Recombinant Hirudin
- Thrombosis Disease
- Tumor Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- The Medicines Company
- Keyken
- Minapharm
- Abbott
- SALUBRIS
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd
- DUOPUTAI
- Pentapharm
What is the 10-year outlook for the global Hirudin market?
What factors are driving Hirudin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hirudin market opportunities vary by end market size?
How does Hirudin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hirudin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hirudin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hirudin by Country/Region, 2020, 2024 & 2031
2.2 Hirudin Segment by Type
2.2.1 Natural Hirudin
2.2.2 Recombinant Hirudin
2.3 Hirudin Sales by Type
2.3.1 Global Hirudin Sales Market Share by Type (2020-2025)
2.3.2 Global Hirudin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hirudin Sale Price by Type (2020-2025)
2.4 Hirudin Segment by Application
2.4.1 Thrombosis Disease
2.4.2 Tumor Disease
2.4.3 Others
2.5 Hirudin Sales by Application
2.5.1 Global Hirudin Sale Market Share by Application (2020-2025)
2.5.2 Global Hirudin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hirudin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hirudin Breakdown Data by Company
3.1.1 Global Hirudin Annual Sales by Company (2020-2025)
3.1.2 Global Hirudin Sales Market Share by Company (2020-2025)
3.2 Global Hirudin Annual Revenue by Company (2020-2025)
3.2.1 Global Hirudin Revenue by Company (2020-2025)
3.2.2 Global Hirudin Revenue Market Share by Company (2020-2025)
3.3 Global Hirudin Sale Price by Company
3.4 Key Manufacturers Hirudin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hirudin Product Location Distribution
3.4.2 Players Hirudin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HIRUDIN BY GEOGRAPHIC REGION
4.1 World Historic Hirudin Market Size by Geographic Region (2020-2025)
4.1.1 Global Hirudin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hirudin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hirudin Market Size by Country/Region (2020-2025)
4.2.1 Global Hirudin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hirudin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hirudin Sales Growth
4.4 APAC Hirudin Sales Growth
4.5 Europe Hirudin Sales Growth
4.6 Middle East & Africa Hirudin Sales Growth
5 AMERICAS
5.1 Americas Hirudin Sales by Country
5.1.1 Americas Hirudin Sales by Country (2020-2025)
5.1.2 Americas Hirudin Revenue by Country (2020-2025)
5.2 Americas Hirudin Sales by Type (2020-2025)
5.3 Americas Hirudin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hirudin Sales by Region
6.1.1 APAC Hirudin Sales by Region (2020-2025)
6.1.2 APAC Hirudin Revenue by Region (2020-2025)
6.2 APAC Hirudin Sales by Type (2020-2025)
6.3 APAC Hirudin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hirudin by Country
7.1.1 Europe Hirudin Sales by Country (2020-2025)
7.1.2 Europe Hirudin Revenue by Country (2020-2025)
7.2 Europe Hirudin Sales by Type (2020-2025)
7.3 Europe Hirudin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hirudin by Country
8.1.1 Middle East & Africa Hirudin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hirudin Revenue by Country (2020-2025)
8.2 Middle East & Africa Hirudin Sales by Type (2020-2025)
8.3 Middle East & Africa Hirudin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hirudin
10.3 Manufacturing Process Analysis of Hirudin
10.4 Industry Chain Structure of Hirudin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hirudin Distributors
11.3 Hirudin Customer
12 WORLD FORECAST REVIEW FOR HIRUDIN BY GEOGRAPHIC REGION
12.1 Global Hirudin Market Size Forecast by Region
12.1.1 Global Hirudin Forecast by Region (2026-2031)
12.1.2 Global Hirudin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hirudin Forecast by Type (2026-2031)
12.7 Global Hirudin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 The Medicines Company
13.1.1 The Medicines Company Company Information
13.1.2 The Medicines Company Hirudin Product Portfolios and Specifications
13.1.3 The Medicines Company Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 The Medicines Company Main Business Overview
13.1.5 The Medicines Company Latest Developments
13.2 Keyken
13.2.1 Keyken Company Information
13.2.2 Keyken Hirudin Product Portfolios and Specifications
13.2.3 Keyken Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Keyken Main Business Overview
13.2.5 Keyken Latest Developments
13.3 Minapharm
13.3.1 Minapharm Company Information
13.3.2 Minapharm Hirudin Product Portfolios and Specifications
13.3.3 Minapharm Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Minapharm Main Business Overview
13.3.5 Minapharm Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Hirudin Product Portfolios and Specifications
13.4.3 Abbott Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 SALUBRIS
13.5.1 SALUBRIS Company Information
13.5.2 SALUBRIS Hirudin Product Portfolios and Specifications
13.5.3 SALUBRIS Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 SALUBRIS Main Business Overview
13.5.5 SALUBRIS Latest Developments
13.6 Pfizer, Inc
13.6.1 Pfizer, Inc Company Information
13.6.2 Pfizer, Inc Hirudin Product Portfolios and Specifications
13.6.3 Pfizer, Inc Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer, Inc Main Business Overview
13.6.5 Pfizer, Inc Latest Developments
13.7 Teva Pharmaceutical Industries Ltd
13.7.1 Teva Pharmaceutical Industries Ltd Company Information
13.7.2 Teva Pharmaceutical Industries Ltd Hirudin Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.8 DUOPUTAI
13.8.1 DUOPUTAI Company Information
13.8.2 DUOPUTAI Hirudin Product Portfolios and Specifications
13.8.3 DUOPUTAI Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 DUOPUTAI Main Business Overview
13.8.5 DUOPUTAI Latest Developments
13.9 Pentapharm
13.9.1 Pentapharm Company Information
13.9.2 Pentapharm Hirudin Product Portfolios and Specifications
13.9.3 Pentapharm Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Pentapharm Main Business Overview
13.9.5 Pentapharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hirudin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hirudin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hirudin by Country/Region, 2020, 2024 & 2031
2.2 Hirudin Segment by Type
2.2.1 Natural Hirudin
2.2.2 Recombinant Hirudin
2.3 Hirudin Sales by Type
2.3.1 Global Hirudin Sales Market Share by Type (2020-2025)
2.3.2 Global Hirudin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hirudin Sale Price by Type (2020-2025)
2.4 Hirudin Segment by Application
2.4.1 Thrombosis Disease
2.4.2 Tumor Disease
2.4.3 Others
2.5 Hirudin Sales by Application
2.5.1 Global Hirudin Sale Market Share by Application (2020-2025)
2.5.2 Global Hirudin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hirudin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hirudin Breakdown Data by Company
3.1.1 Global Hirudin Annual Sales by Company (2020-2025)
3.1.2 Global Hirudin Sales Market Share by Company (2020-2025)
3.2 Global Hirudin Annual Revenue by Company (2020-2025)
3.2.1 Global Hirudin Revenue by Company (2020-2025)
3.2.2 Global Hirudin Revenue Market Share by Company (2020-2025)
3.3 Global Hirudin Sale Price by Company
3.4 Key Manufacturers Hirudin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hirudin Product Location Distribution
3.4.2 Players Hirudin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HIRUDIN BY GEOGRAPHIC REGION
4.1 World Historic Hirudin Market Size by Geographic Region (2020-2025)
4.1.1 Global Hirudin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hirudin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hirudin Market Size by Country/Region (2020-2025)
4.2.1 Global Hirudin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hirudin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hirudin Sales Growth
4.4 APAC Hirudin Sales Growth
4.5 Europe Hirudin Sales Growth
4.6 Middle East & Africa Hirudin Sales Growth
5 AMERICAS
5.1 Americas Hirudin Sales by Country
5.1.1 Americas Hirudin Sales by Country (2020-2025)
5.1.2 Americas Hirudin Revenue by Country (2020-2025)
5.2 Americas Hirudin Sales by Type (2020-2025)
5.3 Americas Hirudin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hirudin Sales by Region
6.1.1 APAC Hirudin Sales by Region (2020-2025)
6.1.2 APAC Hirudin Revenue by Region (2020-2025)
6.2 APAC Hirudin Sales by Type (2020-2025)
6.3 APAC Hirudin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hirudin by Country
7.1.1 Europe Hirudin Sales by Country (2020-2025)
7.1.2 Europe Hirudin Revenue by Country (2020-2025)
7.2 Europe Hirudin Sales by Type (2020-2025)
7.3 Europe Hirudin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hirudin by Country
8.1.1 Middle East & Africa Hirudin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hirudin Revenue by Country (2020-2025)
8.2 Middle East & Africa Hirudin Sales by Type (2020-2025)
8.3 Middle East & Africa Hirudin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hirudin
10.3 Manufacturing Process Analysis of Hirudin
10.4 Industry Chain Structure of Hirudin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hirudin Distributors
11.3 Hirudin Customer
12 WORLD FORECAST REVIEW FOR HIRUDIN BY GEOGRAPHIC REGION
12.1 Global Hirudin Market Size Forecast by Region
12.1.1 Global Hirudin Forecast by Region (2026-2031)
12.1.2 Global Hirudin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hirudin Forecast by Type (2026-2031)
12.7 Global Hirudin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 The Medicines Company
13.1.1 The Medicines Company Company Information
13.1.2 The Medicines Company Hirudin Product Portfolios and Specifications
13.1.3 The Medicines Company Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 The Medicines Company Main Business Overview
13.1.5 The Medicines Company Latest Developments
13.2 Keyken
13.2.1 Keyken Company Information
13.2.2 Keyken Hirudin Product Portfolios and Specifications
13.2.3 Keyken Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Keyken Main Business Overview
13.2.5 Keyken Latest Developments
13.3 Minapharm
13.3.1 Minapharm Company Information
13.3.2 Minapharm Hirudin Product Portfolios and Specifications
13.3.3 Minapharm Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Minapharm Main Business Overview
13.3.5 Minapharm Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Hirudin Product Portfolios and Specifications
13.4.3 Abbott Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 SALUBRIS
13.5.1 SALUBRIS Company Information
13.5.2 SALUBRIS Hirudin Product Portfolios and Specifications
13.5.3 SALUBRIS Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 SALUBRIS Main Business Overview
13.5.5 SALUBRIS Latest Developments
13.6 Pfizer, Inc
13.6.1 Pfizer, Inc Company Information
13.6.2 Pfizer, Inc Hirudin Product Portfolios and Specifications
13.6.3 Pfizer, Inc Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer, Inc Main Business Overview
13.6.5 Pfizer, Inc Latest Developments
13.7 Teva Pharmaceutical Industries Ltd
13.7.1 Teva Pharmaceutical Industries Ltd Company Information
13.7.2 Teva Pharmaceutical Industries Ltd Hirudin Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.8 DUOPUTAI
13.8.1 DUOPUTAI Company Information
13.8.2 DUOPUTAI Hirudin Product Portfolios and Specifications
13.8.3 DUOPUTAI Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 DUOPUTAI Main Business Overview
13.8.5 DUOPUTAI Latest Developments
13.9 Pentapharm
13.9.1 Pentapharm Company Information
13.9.2 Pentapharm Hirudin Product Portfolios and Specifications
13.9.3 Pentapharm Hirudin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Pentapharm Main Business Overview
13.9.5 Pentapharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hirudin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hirudin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Natural Hirudin
Table 4. Major Players of Recombinant Hirudin
Table 5. Global Hirudin Sales byType (2020-2025) & (K MT)
Table 6. Global Hirudin Sales Market Share byType (2020-2025)
Table 7. Global Hirudin Revenue byType (2020-2025) & ($ million)
Table 8. Global Hirudin Revenue Market Share byType (2020-2025)
Table 9. Global Hirudin Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Hirudin Sale by Application (2020-2025) & (K MT)
Table 11. Global Hirudin Sale Market Share by Application (2020-2025)
Table 12. Global Hirudin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Hirudin Revenue Market Share by Application (2020-2025)
Table 14. Global Hirudin Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Hirudin Sales by Company (2020-2025) & (K MT)
Table 16. Global Hirudin Sales Market Share by Company (2020-2025)
Table 17. Global Hirudin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Hirudin Revenue Market Share by Company (2020-2025)
Table 19. Global Hirudin Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Hirudin Producing Area Distribution and Sales Area
Table 21. Players Hirudin Products Offered
Table 22. Hirudin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Hirudin Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Hirudin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Hirudin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Hirudin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Hirudin Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Hirudin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Hirudin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Hirudin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Hirudin Sales by Country (2020-2025) & (K MT)
Table 34. Americas Hirudin Sales Market Share by Country (2020-2025)
Table 35. Americas Hirudin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Hirudin Sales byType (2020-2025) & (K MT)
Table 37. Americas Hirudin Sales by Application (2020-2025) & (K MT)
Table 38. APAC Hirudin Sales by Region (2020-2025) & (K MT)
Table 39. APAC Hirudin Sales Market Share by Region (2020-2025)
Table 40. APAC Hirudin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Hirudin Sales byType (2020-2025) & (K MT)
Table 42. APAC Hirudin Sales by Application (2020-2025) & (K MT)
Table 43. Europe Hirudin Sales by Country (2020-2025) & (K MT)
Table 44. Europe Hirudin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Hirudin Sales byType (2020-2025) & (K MT)
Table 46. Europe Hirudin Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Hirudin Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Hirudin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Hirudin Sales byType (2020-2025) & (K MT)
Table 50. Middle East & Africa Hirudin Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Hirudin
Table 52. Key Market Challenges & Risks of Hirudin
Table 53. Key IndustryTrends of Hirudin
Table 54. Hirudin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Hirudin Distributors List
Table 57. Hirudin Customer List
Table 58. Global Hirudin SalesForecast by Region (2026-2031) & (K MT)
Table 59. Global Hirudin RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Hirudin SalesForecast by Country (2026-2031) & (K MT)
Table 61. Americas Hirudin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Hirudin SalesForecast by Region (2026-2031) & (K MT)
Table 63. APAC Hirudin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Hirudin SalesForecast by Country (2026-2031) & (K MT)
Table 65. Europe Hirudin RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Hirudin SalesForecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Hirudin RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Hirudin SalesForecast byType (2026-2031) & (K MT)
Table 69. Global Hirudin RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Hirudin SalesForecast by Application (2026-2031) & (K MT)
Table 71. Global Hirudin RevenueForecast by Application (2026-2031) & ($ millions)
Table 72.The Medicines Company Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 73.The Medicines Company Hirudin Product Portfolios and Specifications
Table 74.The Medicines Company Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75.The Medicines Company Main Business
Table 76.The Medicines Company Latest Developments
Table 77. Keyken Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 78. Keyken Hirudin Product Portfolios and Specifications
Table 79. Keyken Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Keyken Main Business
Table 81. Keyken Latest Developments
Table 82. Minapharm Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 83. Minapharm Hirudin Product Portfolios and Specifications
Table 84. Minapharm Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Minapharm Main Business
Table 86. Minapharm Latest Developments
Table 87. Abbott Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 88. Abbott Hirudin Product Portfolios and Specifications
Table 89. Abbott Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Abbott Main Business
Table 91. Abbott Latest Developments
Table 92. SALUBRIS Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 93. SALUBRIS Hirudin Product Portfolios and Specifications
Table 94. SALUBRIS Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. SALUBRIS Main Business
Table 96. SALUBRIS Latest Developments
Table 97. Pfizer, Inc Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer, Inc Hirudin Product Portfolios and Specifications
Table 99. Pfizer, Inc Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Pfizer, Inc Main Business
Table 101. Pfizer, Inc Latest Developments
Table 102.Teva Pharmaceutical Industries Ltd Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 103.Teva Pharmaceutical Industries Ltd Hirudin Product Portfolios and Specifications
Table 104.Teva Pharmaceutical Industries Ltd Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105.Teva Pharmaceutical Industries Ltd Main Business
Table 106.Teva Pharmaceutical Industries Ltd Latest Developments
Table 107. DUOPUTAI Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 108. DUOPUTAI Hirudin Product Portfolios and Specifications
Table 109. DUOPUTAI Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. DUOPUTAI Main Business
Table 111. DUOPUTAI Latest Developments
Table 112. Pentapharm Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 113. Pentapharm Hirudin Product Portfolios and Specifications
Table 114. Pentapharm Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. Pentapharm Main Business
Table 116. Pentapharm Latest Developments
Table 1. Hirudin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hirudin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Natural Hirudin
Table 4. Major Players of Recombinant Hirudin
Table 5. Global Hirudin Sales byType (2020-2025) & (K MT)
Table 6. Global Hirudin Sales Market Share byType (2020-2025)
Table 7. Global Hirudin Revenue byType (2020-2025) & ($ million)
Table 8. Global Hirudin Revenue Market Share byType (2020-2025)
Table 9. Global Hirudin Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Hirudin Sale by Application (2020-2025) & (K MT)
Table 11. Global Hirudin Sale Market Share by Application (2020-2025)
Table 12. Global Hirudin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Hirudin Revenue Market Share by Application (2020-2025)
Table 14. Global Hirudin Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Hirudin Sales by Company (2020-2025) & (K MT)
Table 16. Global Hirudin Sales Market Share by Company (2020-2025)
Table 17. Global Hirudin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Hirudin Revenue Market Share by Company (2020-2025)
Table 19. Global Hirudin Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Hirudin Producing Area Distribution and Sales Area
Table 21. Players Hirudin Products Offered
Table 22. Hirudin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Hirudin Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Hirudin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Hirudin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Hirudin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Hirudin Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Hirudin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Hirudin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Hirudin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Hirudin Sales by Country (2020-2025) & (K MT)
Table 34. Americas Hirudin Sales Market Share by Country (2020-2025)
Table 35. Americas Hirudin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Hirudin Sales byType (2020-2025) & (K MT)
Table 37. Americas Hirudin Sales by Application (2020-2025) & (K MT)
Table 38. APAC Hirudin Sales by Region (2020-2025) & (K MT)
Table 39. APAC Hirudin Sales Market Share by Region (2020-2025)
Table 40. APAC Hirudin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Hirudin Sales byType (2020-2025) & (K MT)
Table 42. APAC Hirudin Sales by Application (2020-2025) & (K MT)
Table 43. Europe Hirudin Sales by Country (2020-2025) & (K MT)
Table 44. Europe Hirudin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Hirudin Sales byType (2020-2025) & (K MT)
Table 46. Europe Hirudin Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Hirudin Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Hirudin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Hirudin Sales byType (2020-2025) & (K MT)
Table 50. Middle East & Africa Hirudin Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Hirudin
Table 52. Key Market Challenges & Risks of Hirudin
Table 53. Key IndustryTrends of Hirudin
Table 54. Hirudin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Hirudin Distributors List
Table 57. Hirudin Customer List
Table 58. Global Hirudin SalesForecast by Region (2026-2031) & (K MT)
Table 59. Global Hirudin RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Hirudin SalesForecast by Country (2026-2031) & (K MT)
Table 61. Americas Hirudin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Hirudin SalesForecast by Region (2026-2031) & (K MT)
Table 63. APAC Hirudin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Hirudin SalesForecast by Country (2026-2031) & (K MT)
Table 65. Europe Hirudin RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Hirudin SalesForecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Hirudin RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Hirudin SalesForecast byType (2026-2031) & (K MT)
Table 69. Global Hirudin RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Hirudin SalesForecast by Application (2026-2031) & (K MT)
Table 71. Global Hirudin RevenueForecast by Application (2026-2031) & ($ millions)
Table 72.The Medicines Company Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 73.The Medicines Company Hirudin Product Portfolios and Specifications
Table 74.The Medicines Company Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75.The Medicines Company Main Business
Table 76.The Medicines Company Latest Developments
Table 77. Keyken Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 78. Keyken Hirudin Product Portfolios and Specifications
Table 79. Keyken Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Keyken Main Business
Table 81. Keyken Latest Developments
Table 82. Minapharm Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 83. Minapharm Hirudin Product Portfolios and Specifications
Table 84. Minapharm Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Minapharm Main Business
Table 86. Minapharm Latest Developments
Table 87. Abbott Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 88. Abbott Hirudin Product Portfolios and Specifications
Table 89. Abbott Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Abbott Main Business
Table 91. Abbott Latest Developments
Table 92. SALUBRIS Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 93. SALUBRIS Hirudin Product Portfolios and Specifications
Table 94. SALUBRIS Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. SALUBRIS Main Business
Table 96. SALUBRIS Latest Developments
Table 97. Pfizer, Inc Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer, Inc Hirudin Product Portfolios and Specifications
Table 99. Pfizer, Inc Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Pfizer, Inc Main Business
Table 101. Pfizer, Inc Latest Developments
Table 102.Teva Pharmaceutical Industries Ltd Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 103.Teva Pharmaceutical Industries Ltd Hirudin Product Portfolios and Specifications
Table 104.Teva Pharmaceutical Industries Ltd Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105.Teva Pharmaceutical Industries Ltd Main Business
Table 106.Teva Pharmaceutical Industries Ltd Latest Developments
Table 107. DUOPUTAI Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 108. DUOPUTAI Hirudin Product Portfolios and Specifications
Table 109. DUOPUTAI Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. DUOPUTAI Main Business
Table 111. DUOPUTAI Latest Developments
Table 112. Pentapharm Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
Table 113. Pentapharm Hirudin Product Portfolios and Specifications
Table 114. Pentapharm Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. Pentapharm Main Business
Table 116. Pentapharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hirudin
Figure 2. Hirudin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hirudin Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Hirudin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hirudin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hirudin Sales Market Share by Country/Region (2024)
Figure 10. Hirudin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Natural Hirudin
Figure 12. Product Picture of Recombinant Hirudin
Figure 13. Global Hirudin Sales Market Share byType in 2025
Figure 14. Global Hirudin Revenue Market Share byType (2020-2025)
Figure 15. Hirudin Consumed inThrombosis Disease
Figure 16. Global Hirudin Market:Thrombosis Disease (2020-2025) & (K MT)
Figure 17. Hirudin Consumed inTumor Disease
Figure 18. Global Hirudin Market:Tumor Disease (2020-2025) & (K MT)
Figure 19. Hirudin Consumed in Others
Figure 20. Global Hirudin Market: Others (2020-2025) & (K MT)
Figure 21. Global Hirudin Sale Market Share by Application (2024)
Figure 22. Global Hirudin Revenue Market Share by Application in 2025
Figure 23. Hirudin Sales by Company in 2025 (K MT)
Figure 24. Global Hirudin Sales Market Share by Company in 2025
Figure 25. Hirudin Revenue by Company in 2025 ($ millions)
Figure 26. Global Hirudin Revenue Market Share by Company in 2025
Figure 27. Global Hirudin Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Hirudin Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Hirudin Sales 2020-2025 (K MT)
Figure 30. Americas Hirudin Revenue 2020-2025 ($ millions)
Figure 31. APAC Hirudin Sales 2020-2025 (K MT)
Figure 32. APAC Hirudin Revenue 2020-2025 ($ millions)
Figure 33. Europe Hirudin Sales 2020-2025 (K MT)
Figure 34. Europe Hirudin Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Hirudin Sales 2020-2025 (K MT)
Figure 36. Middle East & Africa Hirudin Revenue 2020-2025 ($ millions)
Figure 37. Americas Hirudin Sales Market Share by Country in 2025
Figure 38. Americas Hirudin Revenue Market Share by Country (2020-2025)
Figure 39. Americas Hirudin Sales Market Share byType (2020-2025)
Figure 40. Americas Hirudin Sales Market Share by Application (2020-2025)
Figure 41. United States Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Hirudin Sales Market Share by Region in 2025
Figure 46. APAC Hirudin Revenue Market Share by Region (2020-2025)
Figure 47. APAC Hirudin Sales Market Share byType (2020-2025)
Figure 48. APAC Hirudin Sales Market Share by Application (2020-2025)
Figure 49. China Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 53. India Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Hirudin Sales Market Share by Country in 2025
Figure 57. Europe Hirudin Revenue Market Share by Country (2020-2025)
Figure 58. Europe Hirudin Sales Market Share byType (2020-2025)
Figure 59. Europe Hirudin Sales Market Share by Application (2020-2025)
Figure 60. Germany Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 61.France Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Hirudin Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Hirudin Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Hirudin Sales Market Share by Application (2020-2025)
Figure 68. Egypt Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Hirudin in 2025
Figure 74. Manufacturing Process Analysis of Hirudin
Figure 75. Industry Chain Structure of Hirudin
Figure 76. Channels of Distribution
Figure 77. Global Hirudin Sales MarketForecast by Region (2026-2031)
Figure 78. Global Hirudin Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Hirudin Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Hirudin Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Hirudin Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Hirudin Revenue Market ShareForecast by Application (2026-2031)
Figure 1. Picture of Hirudin
Figure 2. Hirudin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hirudin Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Hirudin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hirudin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hirudin Sales Market Share by Country/Region (2024)
Figure 10. Hirudin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Natural Hirudin
Figure 12. Product Picture of Recombinant Hirudin
Figure 13. Global Hirudin Sales Market Share byType in 2025
Figure 14. Global Hirudin Revenue Market Share byType (2020-2025)
Figure 15. Hirudin Consumed inThrombosis Disease
Figure 16. Global Hirudin Market:Thrombosis Disease (2020-2025) & (K MT)
Figure 17. Hirudin Consumed inTumor Disease
Figure 18. Global Hirudin Market:Tumor Disease (2020-2025) & (K MT)
Figure 19. Hirudin Consumed in Others
Figure 20. Global Hirudin Market: Others (2020-2025) & (K MT)
Figure 21. Global Hirudin Sale Market Share by Application (2024)
Figure 22. Global Hirudin Revenue Market Share by Application in 2025
Figure 23. Hirudin Sales by Company in 2025 (K MT)
Figure 24. Global Hirudin Sales Market Share by Company in 2025
Figure 25. Hirudin Revenue by Company in 2025 ($ millions)
Figure 26. Global Hirudin Revenue Market Share by Company in 2025
Figure 27. Global Hirudin Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Hirudin Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Hirudin Sales 2020-2025 (K MT)
Figure 30. Americas Hirudin Revenue 2020-2025 ($ millions)
Figure 31. APAC Hirudin Sales 2020-2025 (K MT)
Figure 32. APAC Hirudin Revenue 2020-2025 ($ millions)
Figure 33. Europe Hirudin Sales 2020-2025 (K MT)
Figure 34. Europe Hirudin Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Hirudin Sales 2020-2025 (K MT)
Figure 36. Middle East & Africa Hirudin Revenue 2020-2025 ($ millions)
Figure 37. Americas Hirudin Sales Market Share by Country in 2025
Figure 38. Americas Hirudin Revenue Market Share by Country (2020-2025)
Figure 39. Americas Hirudin Sales Market Share byType (2020-2025)
Figure 40. Americas Hirudin Sales Market Share by Application (2020-2025)
Figure 41. United States Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Hirudin Sales Market Share by Region in 2025
Figure 46. APAC Hirudin Revenue Market Share by Region (2020-2025)
Figure 47. APAC Hirudin Sales Market Share byType (2020-2025)
Figure 48. APAC Hirudin Sales Market Share by Application (2020-2025)
Figure 49. China Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 53. India Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Hirudin Sales Market Share by Country in 2025
Figure 57. Europe Hirudin Revenue Market Share by Country (2020-2025)
Figure 58. Europe Hirudin Sales Market Share byType (2020-2025)
Figure 59. Europe Hirudin Sales Market Share by Application (2020-2025)
Figure 60. Germany Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 61.France Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Hirudin Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Hirudin Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Hirudin Sales Market Share by Application (2020-2025)
Figure 68. Egypt Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Hirudin Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Hirudin in 2025
Figure 74. Manufacturing Process Analysis of Hirudin
Figure 75. Industry Chain Structure of Hirudin
Figure 76. Channels of Distribution
Figure 77. Global Hirudin Sales MarketForecast by Region (2026-2031)
Figure 78. Global Hirudin Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Hirudin Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Hirudin Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Hirudin Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Hirudin Revenue Market ShareForecast by Application (2026-2031)
